Robert T Brodell
Overview
Explore the profile of Robert T Brodell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
600
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bernat A, Brodell R, Dolohanty L
JAAD Case Rep
. 2025 Mar;
57:56-58.
PMID: 40027432
No abstract available.
2.
Reeves C, Islam R, Mockbee C, Helms S, Huynh T, Hughes L, et al.
Arch Dermatol Res
. 2025 Feb;
317(1):343.
PMID: 39912985
There are nearly 45,000 patients for each dermatologist in the rural State of Mississippi, causing many patients to wait months for an appointment in a city that may be hours...
3.
Curtis D, Salmen N, Baumann A, Busby J, Brodell R
Arch Dermatol Res
. 2025 Jan;
317(1):262.
PMID: 39821404
Objectives: To examine the rate of skin color reporting in randomized controlled trials (RCTs) involving melanoma in the top ten highest dermatology journals by impact factor over the past four...
4.
5.
6.
Bui T, Rezac L, Noble C, Velasquez-Evers A, Brodell R
Semin Diagn Pathol
. 2024 Nov;
PMID: 39562259
Background: Targetoid hemosiderotic hemangioma (THH), also known as hobnail lymphatic malformation (HLL) or hobnail hemangioma, is an uncommon, acquired vascular lesion with a dynamic presentation and an unclear etiology. It...
7.
8.
Overton J, Velasquez A, Cruse A, Noble C, Burrow R, Sharma P, et al.
Cureus
. 2024 Oct;
16(9):e69546.
PMID: 39416531
Mucormycosis (zygomycosis) is a severe and often fatal mycotic infection affecting primarily immunocompromised individuals. A 61-year-old female with type 2 diabetes mellitus and end-stage renal disease developed septic shock in...
9.
Santourlidis S, Arauzo-Bravo M, Brodell R, Hassan M, Bendhack M
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000438
Strong epigenetic pan-cancer biomarkers are required to meet several current, urgent clinical needs and to further improve the present chemotherapeutic standard. We have concentrated on the investigation of epigenetic alteration...
10.
Salmen N, Curtis D, Baumann A, Willets J, Brodell R
Arch Dermatol Res
. 2024 Jul;
316(7):451.
PMID: 38967663
Objectives: To determine the rate skin color is reported in randomized controlled trials (RCTs) involving basal cell carcinoma (BCC) identification and treatment in the top ten dermatology journals. Methods: A...